Dividend Information About CME Group: Everything You Need to Know Before Its Ex-Dividend Date of Sep 9, 2025

Generated by AI AgentAinvest Dividend Digest
Friday, Sep 5, 2025 7:01 pm ET1min read
Aime RobotAime Summary

- CME Group declared a $1.25/share dividend, payable Sep 25, 2025, with ex-dividend date set for Sep 9, 2025.

- The payout slightly underperforms its 10-year average ($1.33/share) but follows Q2 2025 revenue growth of 10.4% to $1.69B.

- Analysts maintain a "Hold" rating with $283 price target, citing strong derivatives market leadership and 11% annual dividend growth over a decade.

- Investors must purchase shares by Sep 9 to qualify, as post-ex-dividend transactions will miss the distribution.



CME Group (CME) has announced its upcoming cash dividend of $1.25000000 per share, with an ex-dividend date set for Sep 9, 2025. The company officially declared the dividend on Aug 7, 2025, and it will be distributed to eligible shareholders on Sep 25, 2025. This most recent payout is slightly lower than the average of the last ten dividend amounts, which stood at approximately $1.332289156626506 per share. The last dividend was paid on Jun 25, 2025, also at $1.25000000 per share, with the same cash dividend type. Investors should note that the ex-dividend date marks the final day to purchase shares and still qualify for the current dividend payment—any transactions after this date will not be eligible for the distribution.

Recent developments surrounding highlight strong performance and strategic focus. Over the past week, the company reported a significant revenue surge of 10.4% in Q2 2025, reaching $1.69 billion, driven by a 16% year-over-year growth in average daily volume across all asset classes. Analysts have noted this as a key indicator of CME’s continued leadership in the derivatives market. Additionally, CME Group has maintained a robust track record of dividend growth, with an average annual increase of 11% over the past decade, showcasing its commitment to shareholder returns. Recently, the company also announced that it will release its Q3 2025 earnings on Oct 22, 2025, offering investors the latest insight into its financial health and operational performance.

As of late, CME Group has drawn attention from analysts, with a recent report maintaining a Hold rating on the stock and setting a price target of $283.00, indicating a cautious but positive outlook. While the stock price has experienced a recent decline, dropping $1.92 to close at $267.43 on the last trading day, the broader trend continues to reflect the company’s strong fundamentals and market position. With recent momentum and a strategic focus on risk management and quality financial metrics, CME remains a key player in the derivatives industry. Investors are advised to monitor upcoming earnings and market dynamics as they consider their exposure to this well-established firm.

The ex-dividend date of Sep 9, 2025, is the last day for investors to buy CME shares and receive the upcoming dividend. Any purchases made after this date will not be eligible for the $1.25000000 per share distribution.

Comments



Add a public comment...
No comments

No comments yet